Slovenia tests gene immunotherapy for skin cancer
The Ljubljana Oncology Institute, the country's leading cancer hospital, completed the first phase of the clinical trial for a gene immunotherapy treatment for basal-cell carcinoma of the head and neck, the most common type of skin cancer, CE Report quotes STA.
The first phase has showed that the treatment is safe, feasible and tolerated well by patients.
